russ2000_2_0664|VRCA|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0664|VRCA|Long Name|Verrica Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Verrica Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Verrica Pharmaceuticals Inc Inventories (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Verrica Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Verrica Pharmaceuticals Inc Book Value (Quarterly) (USD)|Verrica Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Verrica Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc EV to Revenues|Verrica Pharmaceuticals Inc EV to Earnings|Verrica Pharmaceuticals Inc EV to Free Cash Flow|Verrica Pharmaceuticals Inc EV to Assets (Quarterly)|Verrica Pharmaceuticals Inc PS Ratio|Verrica Pharmaceuticals Inc PE Ratio|Verrica Pharmaceuticals Inc Price to Book Value|Verrica Pharmaceuticals Inc PEG Ratio|Verrica Pharmaceuticals Inc Debt to Equity Ratio|Verrica Pharmaceuticals Inc Dividend Yield|Verrica Pharmaceuticals Inc Shareholder Yield (TTM)|Verrica Pharmaceuticals Inc Percent of Shares Outstanding Short|Verrica Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Verrica Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Verrica Pharmaceuticals Inc Return on Invested Capital|Verrica Pharmaceuticals Inc Quality Ratio Score|Verrica Pharmaceuticals Inc Momentum Score|Verrica Pharmaceuticals Inc Beta (1Y)|Verrica Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Verrica Pharmaceuticals Inc Institutional Investor Ownership Percentage|Verrica Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Verrica Pharmaceuticals Inc Total Employees (Annual)|Verrica Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Verrica Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Verrica Pharmaceuticals Inc Revenue (Quarterly) (USD)|Verrica Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Verrica Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Verrica Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Verrica Pharmaceuticals Inc Price (USD)|Verrica Pharmaceuticals Inc Total Return Price (USD)|Verrica Pharmaceuticals Inc Enterprise Value (USD)|Verrica Pharmaceuticals Inc 30-Day Average Daily Volume|Verrica Pharmaceuticals Inc 1 Year Price Returns (Daily)||
russ2000_2_0664|VRCA|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0664|VRCA|201703||||||||||||||||||||||||||||||||||19.9464||-0.0286||||0.055|-0.57|-0.57|0|||||||
russ2000_2_0664|VRCA|201706||||||||||||||||||||||||||||||||||19.9464||-0.0549||||0.118|-1.095|-1.095|0|||||||
russ2000_2_0664|VRCA|201709||||||||||||||||||||||||||||||||||19.9464||-0.0681||||0.238|-1.359|-1.359|-0.001|||||||
russ2000_2_0664|VRCA|201712|9.083|8.663||0||16.124|0.616|15.508||-7.041|-12.435|0||||||||||||||0.167|0|||||||19.9464|11|-0.3377||||0.316|-1.435|-1.435|-0.001|||||||
russ2000_2_0664|VRCA|201803|28.905|27.485||0.019||1.648|1.648|0||27.748|-14.309|0||||||||||||||0.618|0.002|||||||24.9464||-0.074||||0.961|-1.847|-1.847|0.041|||||||
russ2000_2_0664|VRCA|201806|104.59|103.149||0.112||3.125|3.125|0||101.591|-20.268|0|||-74.6158||||17.7379|||0||0.1227||1.117|0.003|||||||5.7513|11|-0.92||||1.955|-5.317|-5.317|0.153|19.73|19.73|464.7075|||19.88|19.88
russ2000_2_0664|VRCA|201809|98.677|96.975||0.114||2.451|2.451|0||96.354|-27.007|0|||-35.9088||||4.1103|||0||0.6617||1.105|0.003|||||||24.8475|15|-0.24||||2.865|-5.906|-5.906|0.427|16.25|16.25|314.4175|100175.4667||16.12|16.12
russ2000_2_0664|VRCA|201812|91.152|89.809||0.255||2.477|2.477|0||89.429|-33.083||||-6.4181||||2.3426|||0||0.5482||0.96|0.003|||||||25.7048|16|-0.3||||3.271|-7.578|-7.578|0.61|8.15|8.15|119.6851|42005.3||7.95|7.95
russ2000_2_0664|VRCA|201903|84.677|83.282||1.288||3.218|3.062|0.156||82.761|-40.464|0|||-10.0862||||3.1074|||0||2.389|0.006|1.136|0.003|||||||24.8578||-0.3||||3.539|-7.479|-7.479|0.547|10.81|10.81|188.0869|75228.5||10.34|10.34
russ2000_2_0664|VRCA|201906|79.739|78.754||1.497||4.405|4.281|0.124||76.845|-47.465|0|||-9.2097||||3.6096|||0||2.8177||1.473|0.003||||3.9747|||24.8756||-0.28||||3.593|-7.001|-7.001|0.523|11.62|11.62|215.4508|57742.5333|-40.7143|12.26|12.26
russ2000_2_0664|VRCA|201909|74.04|71.078||2||4.421|4.33|0.091||71.653|-53.555|0|||-11.2632||||5.3032|||0||2.221||1.01|0.003|||3|4.5136||58.6749|24.893||-0.24||||3.494|-6.09|-6.09|0.453|14.76|14.76|308.9152|62127.7333|-9.1692|14.43|14.43
russ2000_2_0664|VRCA|201912|64.983|62.017||2.201||3.409|3.351|0.058||65.015|-61.192||||-12.379||||6.3023|||0||2.2234||1.185|0.003|||9|5.6428||74.2917|24.9648|17|-0.31||||4.018|-7.637|-7.637|0.354|15.89|15.89|347.7273|90379.9667|94.9693|15.26|15.26
russ2000_2_0664|VRCA|202003|90.647|88.382||2.42||37.834|3.302|34.532||56.608|-71.014|0|||-7.6635||||4.9843|||0||3.0879||1.103|0.003|||7|2.8626||71.7619|24.9642||-0.39||||4.988|-9.822|-9.822|0.058|10.93|10.93|228.2045|75183.1333|1.1101|9.02|9.02
russ2000_2_0664|VRCA|202006|83.338|79.622||2.517||38.773|38.698|0.075||48.463|-80.423|0|||-7.157||||5.8646|||0||3.2167||1.297|0.003|||9|1.1649||59.9166|24.9656||-0.38||||5.11|-9.409|-9.409|-0.778|11.01|11.01|239.3156|74364.5333|-5.2496|10.16|10.16
russ2000_2_0664|VRCA|202009|||||||||||||||-4.6325||||4.1228|||0||9.8796||||||4|1.1071||58.4381|||||||||||7.74|7.74|154.9022|236509.4667|-47.561|7.61|7.61